학술논문

Lenzilumab in Addition to Azacitidine Improves Complete Response Rates in Chronic Myelomonocytic Leukemia
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 4p. Supplement: 1
Subject
Language
English
ISSN
15280020